2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Mixed Dyslipidemias: new trials by email Literature Review of Mixed Dyslipidemias trials Research Report on Mixed Dyslipidemias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia Pitavastatin, Ezetimibe, 1PC111 - Primary Hypercholesterolemia, Mixed Dyslipidemias | Phase 3 | Completed | Orient Pharma Co., Ltd. | 390 | 2020-08-01 | 2022-05-18 |
| Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia Rosuvastatin, Fenofibrate - Mixed Dyslipidemias | Phase 3 | Completed | IlDong Pharmaceutical Co Ltd | 362 | 2014-11-01 | 2018-08-24 |
Ezetimibe (1) · Fenofibrate (1) · Rosuvastatin Calcium (1) · pitavastatin (1)
IlDong Pharmaceutical Co Ltd (1) · Orient Pharma Co., Ltd. (1)
Australia (1) · New Zealand (1) · South Korea (1) · Taiwan (1)
Jeongtaeck Woo, M.D., Ph.D (1)